Literature DB >> 6432697

Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats.

M J Thomassen, J D Klinger, G B Winnie, R E Wood, C Burtner, J F Tomashefski, J G Horowitz, B Tandler.   

Abstract

A model of chronic pulmonary infection was used for studying cellular events in a sequential manner. In this model, agarose beads containing Pseudomonas aeruginosa were instilled endotracheally into cats. Nine cats were inoculated with agarose beads containing P. aeruginosa, and four others were inoculated with sterile beads. With a fiberoptic bronchoscope, bronchial washings were obtained biweekly for up to 30 weeks. The quantitative pulmonary inflammatory cell response and alveolar macrophage morphology of the animals exposed to P. aeruginosa were compared with those for the animals exposed to a chronic irritant (agarose beads). Bronchial washings of all animals before inoculation showed that 70 to 90% of the cells were macrophages. After inoculation with P. aeruginosa, a persistent inflammatory response was observed (60 to 70% granulocytes). In the sterile-bead-inoculated group, the response was less prominent (30 to 40% granulocytes). As early as 2 weeks after inoculation, alveolar macrophages from infected animals were larger and had cytoplasmic features that differed from those of controls. Electron microscope examination showed prominent surface alterations in alveolar macrophages from the infected cats. These alterations persisted from 2 to 12 weeks after infection. In animals inoculated with sterile beads, alveolar macrophages exhibited less extensive surface changes that had resolved by week 8. Histologically, chronic bronchiolitis and pneumonia were more severe in the infected animals than in controls. This model of chronic inflammation and macrophage stimulation, which is similar to the chronic pneumonia of cystic fibrosis, may be a useful approach to answer questions on the role of macrophage activation in chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432697      PMCID: PMC263360          DOI: 10.1128/iai.45.3.741-747.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 2.  Activation of mononuclear phagocytes: fact, fancy, and future.

Authors:  Z A Cohn
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 3.  The concept of the activated macrophage.

Authors:  R J North
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

5.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Authors:  H A Cash; D E Woods; B McCullough; W G Johanson; J A Bass
Journal:  Am Rev Respir Dis       Date:  1979-03

6.  Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages.

Authors:  M J Thomassen; B Boxerbaum; C A Demko; P J Kuchenbrod; D G Dearborn; R E Wood
Journal:  Pediatr Res       Date:  1979-09       Impact factor: 3.756

7.  Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

Authors:  N Holby; S Olling
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-04

8.  Ultrastructure and function of alveolar macrophages from cystic fibrosis patients.

Authors:  M J Thomassen; C A Demko; R E Wood; B Tandler; D G Dearborn; B Boxerbaum; P J Kuchenbrod
Journal:  Pediatr Res       Date:  1980-05       Impact factor: 3.756

9.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.

Authors:  G M GREEN; E H KASS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  7 in total

1.  Bronchoalveolar lavage in the cat: cytological findings.

Authors:  G M McCarthy; P J Quinn
Journal:  Can J Vet Res       Date:  1989-07       Impact factor: 1.310

2.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

3.  Modular microfluidic system as a model of cystic fibrosis airways.

Authors:  M Skolimowski; M Weiss Nielsen; F Abeille; P Skafte-Pedersen; D Sabourin; A Fercher; D Papkovsky; S Molin; R Taboryski; C Sternberg; M Dufva; O Geschke; J Emnéus
Journal:  Biomicrofluidics       Date:  2012-08-02       Impact factor: 2.800

4.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

5.  In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa.

Authors:  M M Stevenson; T K Kondratieva; A S Apt; M F Tam; E Skamene
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

Review 6.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13

7.  A lung segmental model of chronic Pseudomonas infection in sheep.

Authors:  David Collie; John Govan; Steven Wright; Elisabeth Thornton; Peter Tennant; Sionagh Smith; Catherine Doherty; Gerry McLachlan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.